GlassScriptPhysician profile
Amish Kumar Dudeja
NPI 1912429002
$5,542.83
in general payments reported to CMS, 2019-2025
28 companies · $296 in 2025
The $296 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,484 · 2020: $565 · 2021: $832 · 2022: $711 · 2023: $199 · 2024: $1,457 · 2025: $296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,073 · Travel and Lodging: $878.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,072.78 |
| Travel and Lodging | $878.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,464.25 | 2019-2025 | Ortholoc 3di, Salvation |
| Smith+Nephew, INC. | $1,134.45 | 2019-2025 | Grafix, Grafix Xc, Grafix Pl |
| Medical Device Business Services, INC. | $1,006.22 | 2024 | |
| Depuy Synthes Sales INC. | $392.81 | 2021-2025 | Motoband, Minibunion, Motoband Cp |
| Melinta Therapeutics, LLC | $251.89 | 2019-2022 | |
| Integra Lifesciences Corporation | $224.13 | 2019-2022 | |
| Bone Support INC. | $154.86 | 2024 | Cerament G, Ceramentbone Void Filler |
| Paragon 28, INC. | $121.20 | 2019 | |
| Medtronic, INC. | $117.35 | 2024 | Hawkone |
| Derma Sciences, INC. | $102.71 | 2019 | |
| Ets Wound Care LLC | $80.81 | 2025 | Mirragen Advanced Wound Matrix |
| Medline Industries LP | $68.35 | 2020 | |
| Treace Medical Concepts, INC. | $59.75 | 2023-2025 | |
| Kerecis Limited | $53.93 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Organogenesis INC. | $42.38 | 2024 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $41.75 | 2022-2023 | Senza |
| Medartis INC. | $26.12 | 2020 | |
| Averitas Pharma INC. | $24.98 | 2023 | Qutenza |
| Paratek Pharmaceuticals, INC. | $24.95 | 2021-2023 | Nuzyra |
| Acera Surgical, INC. | $23.77 | 2025 | Restrata Wound Matrix |
| Triad Life Sciences INC. | $21.84 | 2022 | |
| Zimmer Biomet Holdings, INC. | $18.66 | 2021 | |
| Djo, LLC | $18.01 | 2025 | Cmf |
| Kowa Pharmaceuticals America, INC. | $15.44 | 2022 | |
| Polynovo North America LLC | $14.12 | 2023 | |
| Heron Therapeutics, INC. | $14.06 | 2021 | |
| Zimvie INC. | $12.67 | 2022 | |
| Arteriocyte Medical Systems, INC. | $11.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amish Dudeja listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.